Nordic ListingsIssuer Report
Ambu A/S: Quarterly Trading Report 2025 Q2
Ambu A/S: Quarterly Trading Report 2025 Q2https://view.news.eu.nasdaq.com/view?id=be31edf5a46c53b954c09c4f5b286d983&lang=en&src=omxlink
Ambu A/S: Quarterly Trading Report 2025 Q2
Watch Ambu's latest callAmbu (Copenhagen:AMBU B) Q3 2026 Earnings Call · Replay · Aug 26Read the transcript of Ambu (Copenhagen:AMBU B) Q3 2026 Earnings CallStory so far
Earlier from Ambu
- Ambu rises as FDA issues import alerts on rival devices
- Ambu Obtains FDA Clearance For Single-Use Flexible Cysto-Nephroscopy Solution
- Ambu A/S: Annual Trading Report 2024
- Ambu A/S: Quarterly Trading Report 2025 Q1
- AMBU_B: Strong Q2 growth and margin, guidance reaffirmed amid tariff and currency headwinds
Later from Ambu
- Ambu A/S: Quarterly Trading Report 2024 Q4
- AMBU_B: Strong Q3 growth and raised guidance, despite FX and working capital headwinds
- AMBU_B: Ambitious strategy aims for global endoscopy leadership, 11%-13% CAGR, and 20%+ EBIT margin
- Ambu A/S: Quarterly Trading Report 2025 Q3
- AMBU_B: Strong double-digit growth and margin expansion, with robust outlook despite FX and tariff headwinds
Follow Ambu into a list and get an email when it puts out news.
Follow Ambu